Literature DB >> 7821846

Isolation and preliminary characterization of an ovarian carcinoma cell line from a patient with familial ovarian cancer.

R E Buller1, T Niemann, J P Connor, R C Squatrito, J S Skilling, B Anderson.   

Abstract

An epithelial ovarian cancer cell line is established from a patient with recurrent familial ovarian cancer. Two of the patient's sisters and her mother have also had ovarian cancer. The histological resemblance of the cell line to the patient's Stage IV, Grade 3 papillary serous ovarian primary cancer is striking. The cell line does not secrete CA125 and is estrogen and progesterone receptor negative. Overexpression of the p53 tumor suppressor gene but not the HER-2/neu oncogene was detected by immunohistochemical analysis. An unusual chemosensitivity to cisplatin, doxorubicin, etoposide, and taxol is demonstrated, suggesting that a chemosensitivity mechanism might explain prolonged survival of some patients with familial ovarian cancers. This truly unique cell line should prove invaluable in the further evaluation of molecular genetic changes associated with familial ovarian cancers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7821846     DOI: 10.1006/gyno.1995.1007

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Characterization of four novel epithelial ovarian cancer cell lines.

Authors:  D M Provencher; H Lounis; L Champoux; M Tétrault; E N Manderson; J C Wang; P Eydoux; R Savoie; P N Tonin; A M Mes-Masson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

2.  A new cell line from human undifferentiated carcinoma of the ovary: establishment and characterization.

Authors:  J W Kim; C G Lee; M S Lyu; H K Kim; J G Rha; D H Kim; S J Kim; S E Namkoong
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Characterization of three new serous epithelial ovarian cancer cell lines.

Authors:  Véronique Ouellet; Magdalena Zietarska; Lise Portelance; Julie Lafontaine; Jason Madore; Marie-Line Puiffe; Suzanna L Arcand; Zhen Shen; Josée Hébert; Patricia N Tonin; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  BMC Cancer       Date:  2008-05-28       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.